User profiles for C.R. Jenkins

Christine Jenkins

- Verified email at sydney.edu.au - Cited by 37061

Charles Jenkins

- Verified email at csiro.au - Cited by 4069

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung …

…, AS Buist, PMA Calverley, CR Jenkins… - American journal of …, 2001 - atsjournals.org
… However, this therapy is very expensive, is not available in most countries, and is not
recommended for COPD that is not related to α 1 -antitrypsin deficiency (Evidence C). … In …

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

…, JA Anderson, GT Ferguson, CR Jenkins… - American journal of …, 2008 - atsjournals.org
Rationale: Chronic obstructive pulmonary disease (COPD) is characterized by an accelerated
decline in lung function. No drug has been shown conclusively to reduce this decline. …

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health …

RA Pauwels, AS Buist, P Ma, CR Jenkins… - Respiratory …, 2001 - pubmed.ncbi.nlm.nih.gov
… RA Pauwels, AS Buist, P Ma, CR Jenkins, SS Hurd; GOLD Scientific Committee …

[BOOK][B] Practical statistics for astronomers

JV Wall, CR Jenkins - 2012 - books.google.com
… The argument is originally due to Cox (1946) and goes as follows: if A, B and C are three
events and we wish to have some measure of how strongly we think each is likely to happen, …

[HTML][HTML] Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled …

CR Jenkins, PW Jones, PMA Calverley, B Celli… - Respiratory …, 2009 - Springer
Background The efficacy of inhaled salmeterol plus fluticasone propionate (SFC) in patients
with severe or very severe COPD is well documented. However, there are only limited data …

Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment

IA Yang, CR Jenkins, SS Salvi - The Lancet Respiratory Medicine, 2022 - thelancet.com
Chronic obstructive pulmonary disease (COPD) was traditionally thought to be caused by
tobacco smoking. However, recognition of the importance of non-smoking-related risk factors …

Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids

JD Leuppi, CM Salome, CR Jenkins… - American journal of …, 2001 - atsjournals.org
To determine predictors for failed reduction of inhaled corticosteroids (ICS), in 50 subjects
with well-controlled asthma (age 43.7 [18–69]; 22 males) taking a median dose of 1,000 μ g …

[HTML][HTML] Ionized gas in elliptical and S0 galaxies. IA survey for H-alpha and forbidden N II emission

MM Phillips, CR Jenkins, MA Dopita… - … Journal (ISSN 0004 …, 1986 - adsabs.harvard.edu
CR JENKINS … same width; for type C, we fitted lines of FWHM = 329 … scaling factor to
our estimate of c, which is present in any …

Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study

…, PMA Calverley, JA Anderson, CR Jenkins… - Chest, 2009 - Elsevier
Background Osteoporosis is common in patients with COPD, but its prevalence and progression
are not well characterized. Concerns have been raised over the possible deleterious …

[BOOK][B] Towards a theory of self-administered questionnaire design

CR Jenkins, DA Dillman - 1995 - census.gov
Opinions expressed in this paper are those of the authors 1 and should not be construed as
representing those of either the US Bureau of the Census or Washington State University. At …